These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 15284201

  • 1. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
    Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y.
    Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
    [Abstract] [Full Text] [Related]

  • 2. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y, Zheng YF, Luo QQ, Yan T, Liu XX, Han L, Zou L.
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [Abstract] [Full Text] [Related]

  • 3. Lymphokine-activated killer cells induced from decidual lymphocytes reduce the angiogenic activity of trophoblasts by enhancing the release of soluble fms-like tyrosine kinase-1 from trophoblasts: an implication for the pathophysiology of preeclampsia.
    Matsubara K, Nagamatsu T, Fujii T, Kozuma S, Taketani Y.
    J Reprod Immunol; 2005 Dec; 68(1-2):27-37. PubMed ID: 16229897
    [Abstract] [Full Text] [Related]

  • 4. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
    Huang QT, Zhang M, Zhong M, Yu YH, Liang WZ, Hang LL, Gao YF, Huang LP, Wang ZJ.
    Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
    [Abstract] [Full Text] [Related]

  • 5. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
    Maebayashi Asanuma A, Yamamoto T, Azuma H, Kato E, Yamamoto N, Murase T, Chishima F, Suzuki M.
    J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
    [Abstract] [Full Text] [Related]

  • 6. Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia.
    Zhao Y, Koga K, Osuga Y, Nagai M, Izumi G, Takamura M, Harada M, Hirota Y, Yoshino O, Taketani Y.
    Fertil Steril; 2012 Oct; 98(4):917-21. PubMed ID: 22819145
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
    Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C, Weich H, Whittle M, Ahmed A.
    Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
    [Abstract] [Full Text] [Related]

  • 8. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S, Ahmed A.
    Circ Res; 2004 Oct 29; 95(9):884-91. PubMed ID: 15472115
    [Abstract] [Full Text] [Related]

  • 9. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
    Saad AF, Kechichian T, Yin H, Sbrana E, Longo M, Wen M, Tamayo E, Hankins GD, Saade GR, Costantine MM.
    Reprod Sci; 2014 Jan 29; 21(1):138-45. PubMed ID: 23749761
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S, Frankenne F, Foidart JM.
    Hum Reprod; 2008 Jun 29; 23(6):1407-15. PubMed ID: 18413304
    [Abstract] [Full Text] [Related]

  • 11. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM, Roland MC, Henriksen T, Michelsen TM.
    Am J Obstet Gynecol; 2016 Dec 29; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.
    Li H, Gu B, Zhang Y, Lewis DF, Wang Y.
    Placenta; 2005 Dec 29; 26(2-3):210-7. PubMed ID: 15708122
    [Abstract] [Full Text] [Related]

  • 13. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S, Kaitu'u-Lino TJ, Onda K, Beard S, Hastie R, Binder NK, Cluver C, Tuohey L, Whitehead C, Brownfoot F, De Silva M, Hannan NJ.
    Hypertension; 2015 Nov 29; 66(5):1073-81. PubMed ID: 26324507
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.
    Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C, Fisher SJ.
    Am J Pathol; 2002 Apr 29; 160(4):1405-23. PubMed ID: 11943725
    [Abstract] [Full Text] [Related]

  • 15. Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia.
    Zhou Q, Qiao FY, Zhao C, Liu HY.
    Cell Biol Int; 2011 Jan 29; 35(1):61-6. PubMed ID: 20828367
    [Abstract] [Full Text] [Related]

  • 16. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC, Hastie R, Hannan NJ, Cannon P, Tuohey L, Parry LJ, Senadheera S, Illanes SE, Kaitu'u-Lino TJ, Tong S.
    Am J Obstet Gynecol; 2016 Mar 29; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
    Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, Schaaps JP, Cabrol D, Frankenne F, Foidart JM.
    J Clin Endocrinol Metab; 2003 Nov 29; 88(11):5555-63. PubMed ID: 14602804
    [Abstract] [Full Text] [Related]

  • 18. VEGF (Vascular Endothelial Growth Factor) Functionalized Magnetic Beads in a Microfluidic Device to Improve the Angiogenic Balance in Preeclampsia.
    Trapiella-Alfonso L, Alexandre L, Fraichard C, Pons K, Dumas S, Huart L, Gaucher JF, Hebert-Schuster M, Guibourdenche J, Fournier T, Vidal M, Broutin I, Lecomte-Raclet L, Malaquin L, Descroix S, Tsatsaris V, Gagey-Eilstein N, Lecarpentier E.
    Hypertension; 2019 Jul 29; 74(1):145-153. PubMed ID: 31079531
    [Abstract] [Full Text] [Related]

  • 19. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
    Ahmed A, Dunk C, Ahmad S, Khaliq A.
    Placenta; 2000 Jul 29; 21 Suppl A():S16-24. PubMed ID: 10831117
    [Abstract] [Full Text] [Related]

  • 20. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA.
    J Clin Endocrinol Metab; 2005 Aug 29; 90(8):4895-903. PubMed ID: 15886253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.